title: Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
authors.affiliation: Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA. sadda@usc.edu
authors.forename: Srinivas R
authors.initials: SR
authors.lastname: Sadda
authors.forename: Glenn
authors.initials: G
authors.lastname: Stoller
authors.forename: David S
authors.initials: DS
authors.lastname: Boyer
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Blodi
authors.forename: Howard
authors.initials: H
authors.lastname: Shapiro
authors.forename: Tsontcho
authors.initials: T
authors.lastname: Ianchulev